150 related articles for article (PubMed ID: 30231570)
1. Soluble Toll-Like Receptor 4 Impairs the Interaction of Shiga Toxin 2a with Human Serum Amyloid P Component.
Brigotti M; Arfilli V; Carnicelli D; Ricci F; Tazzari PL; Ardissino G; Scavia G; Morabito S; He X
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30231570
[TBL] [Abstract][Full Text] [Related]
2. Identification of TLR4 as the receptor that recognizes Shiga toxins in human neutrophils.
Brigotti M; Carnicelli D; Arfilli V; Tamassia N; Borsetti F; Fabbri E; Tazzari PL; Ricci F; Pagliaro P; Spisni E; Cassatella MA
J Immunol; 2013 Nov; 191(9):4748-58. PubMed ID: 24068665
[TBL] [Abstract][Full Text] [Related]
3. Method for the Detection of the Cleaved Form of Shiga Toxin 2a Added to Normal Human Serum.
Rocchetti L; Munari B; Varrone E; Porcellini E; Orth-Höller D; Würzner R; Carnicelli D; Brigotti M
Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33530614
[TBL] [Abstract][Full Text] [Related]
4. AB5 Preassembly Is Not Required for Shiga Toxin Activity.
Pellino CA; Karve SS; Pradhan S; Weiss AA
J Bacteriol; 2016 Jun; 198(11):1621-1630. PubMed ID: 27002129
[TBL] [Abstract][Full Text] [Related]
5. An Improved Method for the Sensitive Detection of Shiga Toxin 2 in Human Serum.
He X; Ardissino G; Patfield S; Cheng LW; Silva CJ; Brigotti M
Toxins (Basel); 2018 Jan; 10(2):. PubMed ID: 29385045
[TBL] [Abstract][Full Text] [Related]
6. Shiga Toxin 2a-Induced Endothelial Injury in Hemolytic Uremic Syndrome: A Metabolomic Analysis.
Betzen C; Plotnicki K; Fathalizadeh F; Pappan K; Fleming T; Bielaszewska M; Karch H; Tönshoff B; Rafat N
J Infect Dis; 2016 Mar; 213(6):1031-40. PubMed ID: 26582960
[TBL] [Abstract][Full Text] [Related]
7. Combining Mass Spectrometry, Surface Acoustic Wave Interaction Analysis, and Cell Viability Assays for Characterization of Shiga Toxin Subtypes of Pathogenic Escherichia coli Bacteria.
Steil D; Pohlentz G; Legros N; Mormann M; Mellmann A; Karch H; Müthing J
Anal Chem; 2018 Aug; 90(15):8989-8997. PubMed ID: 29939014
[TBL] [Abstract][Full Text] [Related]
8. Role of Shiga toxin 2 (Stx2)-binding protein, human serum amyloid P component (HuSAP), in Shiga toxin-producing Escherichia coli infections: assumption from in vitro and in vivo study using HuSAP and anti-Stx2 humanized monoclonal antibody TMA-15.
Kimura T; Tani S; Motoki M; Matsumoto Y
Biochem Biophys Res Commun; 2003 Jun; 305(4):1057-60. PubMed ID: 12767937
[TBL] [Abstract][Full Text] [Related]
9. Shiga Toxin (Stx) Type 1a Reduces the Oral Toxicity of Stx Type 2a.
Russo LM; Melton-Celsa AR; O'Brien AD
J Infect Dis; 2016 Apr; 213(8):1271-9. PubMed ID: 26743841
[TBL] [Abstract][Full Text] [Related]
10. Exosomes released from Shiga toxin 2a-treated human macrophages modulate inflammatory responses and induce cell death in toxin receptor expressing human cells.
Lee KS; Lee J; Lee P; Kim CU; Kim DJ; Jeong YJ; Park YJ; Tesh VL; Lee MS
Cell Microbiol; 2020 Nov; 22(11):e13249. PubMed ID: 32772454
[TBL] [Abstract][Full Text] [Related]
11. Oral intoxication of mice with Shiga toxin type 2a (Stx2a) and protection by anti-Stx2a monoclonal antibody 11E10.
Russo LM; Melton-Celsa AR; Smith MA; Smith MJ; O'Brien AD
Infect Immun; 2014 Mar; 82(3):1213-21. PubMed ID: 24379294
[TBL] [Abstract][Full Text] [Related]
12. The Antibiotic Polymyxin B Impairs the Interactions between Shiga Toxins and Human Neutrophils.
Carnicelli D; Arfilli V; Ricci F; Velati C; Tazzari PL; Brigotti M
J Immunol; 2016 Feb; 196(3):1177-85. PubMed ID: 26695372
[TBL] [Abstract][Full Text] [Related]
13. Differential binding of Shiga toxin 2 to human and murine neutrophils.
Griener TP; Mulvey GL; Marcato P; Armstrong GD
J Med Microbiol; 2007 Nov; 56(Pt 11):1423-1430. PubMed ID: 17965340
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for the interaction of Shiga toxin 2a with a C-terminal peptide of ribosomal P stalk proteins.
Rudolph MJ; Davis SA; Tumer NE; Li XP
J Biol Chem; 2020 Nov; 295(46):15588-15596. PubMed ID: 32878986
[TBL] [Abstract][Full Text] [Related]
15. Shiga toxin-producing Escherichia coli strains from cattle as a source of the Stx2a bacteriophages present in enteroaggregative Escherichia coli O104:H4 strains.
Beutin L; Hammerl JA; Reetz J; Strauch E
Int J Med Microbiol; 2013 Dec; 303(8):595-602. PubMed ID: 24012149
[TBL] [Abstract][Full Text] [Related]
16. Recent progress of Shiga toxin neutralizer for treatment of infections by Shiga toxin-producing Escherichia coli.
Nishikawa K
Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):239-47. PubMed ID: 21644029
[TBL] [Abstract][Full Text] [Related]
17. The structure of the Shiga toxin 2a A-subunit dictates the interactions of the toxin with blood components.
Brigotti M; Orth-Höller D; Carnicelli D; Porcellini E; Galassi E; Tazzari PL; Ricci F; Manoli F; Manet I; Talasz H; Lindner HH; Speth C; Erbeznik T; Fuchs S; Posch W; Chatterjee S; Würzner R
Cell Microbiol; 2019 May; 21(5):e13000. PubMed ID: 30578712
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 4 facilitates binding of Shiga toxin to colon carcinoma and primary umbilical vein endothelial cells.
Torgersen ML; Engedal N; Pedersen AM; Husebye H; Espevik T; Sandvig K
FEMS Immunol Med Microbiol; 2011 Feb; 61(1):63-75. PubMed ID: 21054580
[TBL] [Abstract][Full Text] [Related]
19. Shiga Toxin 2a Induces NETosis via NOX-Dependent Pathway.
Feitz WJC; Suntharalingham S; Khan M; Ortiz-Sandoval CG; Palaniyar N; van den Heuvel LP; van de Kar NCAJ; Licht C
Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944623
[TBL] [Abstract][Full Text] [Related]
20. The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7.
Carey CM; Kostrzynska M; Ojha S; Thompson S
J Microbiol Methods; 2008 May; 73(2):125-32. PubMed ID: 18328583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]